Sort   by:  
 Page size 
UnknownGreener Operations: a James Lind Alliance Priority Setting Partnership to define research priorities in environmentally sustainable perioperative practice through a structured consensus approach.
Not available
S-EPMC10069275 | biostudies-literature
UnknownPlasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis.
Not available
S-EPMC12010051 | biostudies-literature
TranscriptomicsCalu6 and LoVo xenograft mRNA expression profiles in response to cediranib treatment
Calu6 and LoVo xenograft mRNA expression profiles in response to cediranib treatment
ORGANISM(S): Homo sapiens 
2013-09-09 | E-MTAB-1627 | biostudies-arrayexpress
UnknownAssociations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study.
Not available
S-EPMC6744368 | biostudies-literature
UnknownHigh-intensity interval exercise training before abdominal aortic aneurysm repair (HIT-AAA): protocol for a randomised controlled feasibility trial.
Not available
S-EPMC3902383 | biostudies-literature
UnknownBeliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.
Not available
S-EPMC6656513 | biostudies-literature
UnknownInterferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial.
Not available
S-EPMC2835851 | biostudies-literature
UnknownImaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Secondary Analysis of RTOG 1016.
Not available
S-EPMC13522994 | biostudies-literature
UnknownA New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps.
Not available
S-EPMC11816175 | biostudies-literature
UnknownOlanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602).
Not available
S-EPMC10400142 | biostudies-literature
Sort   by:  
 Page size